Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Sep 15;102(6):1183–1192. doi: 10.1172/JCI3206

A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.

S Honda 1, Y Tomiyama 1, M Shiraga 1, S Tadokoro 1, J Takamatsu 1, H Saito 1, Y Kurata 1, Y Matsuzawa 1
PMCID: PMC509101  PMID: 9739052

Abstract

The ligand binding site(s) of the alpha subunit of integrin alphaIIb beta3 (GPIIb-IIIa), a prototypic non-I domain integrin, remains elusive. In this study, we have characterized a Japanese variant of Glanzmann thrombasthenia, KO, whose platelets express normal amounts of alphaIIb beta3. KO platelets failed to bind the activation-independent ligand-mimetic mAb OP-G2 and did not bind fibrinogen or the activation-dependent ligand-mimetic mAb PAC-1 following activation of alphaIIb beta3 under any condition examined. Sequence analysis of PCR fragments derived from KO platelet mRNA revealed a 6-bp insertion leading to a 2-amino-acid insertion (Arg-Thr) between residues 160 and 161 of the alphaIIb subunit. Introduction of the insertion into wild-type recombinant alphaIIb beta3 expressed in 293 cells led to the normal expression of alphaIIb beta3 having the defect in ligand binding function. The insertion is located within the small loop (Cys146-Cys167) in the third NH2-terminal repeat of the alphaIIb subunit. Alanine substitution of each of the oxygenated residues within the loop (Thr150, Ser152, Glu157, Asp159, Ser161, and Asp163) did not significantly affect expression of alphaIIbbeta3, and only Asp163AlaalphaIIb beta3 abolished the ligand binding function. In addition, Asp163AlaalphaIIb beta3 as well as KO mutant alphaIIb beta3 constitutively expressed the PMI-1 epitope. Our present data suggest that Asp163 of the alphaIIb subunit is one of the critical residues for ligand binding.

Full Text

The Full Text of this article is available as a PDF (306.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Cox D., Senzaki K., Seki J., Tanaka A., Takasugi H., Motoyama Y. The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIB/IIIA antagonist. Thromb Res. 1996 Feb 15;81(4):439–450. doi: 10.1016/0049-3848(96)00016-3. [DOI] [PubMed] [Google Scholar]
  2. Bajt M. L., Ginsberg M. H., Frelinger A. L., 3rd, Berndt M. C., Loftus J. C. A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J Biol Chem. 1992 Feb 25;267(6):3789–3794. [PubMed] [Google Scholar]
  3. Bajt M. L., Loftus J. C. Mutation of a ligand binding domain of beta 3 integrin. Integral role of oxygenated residues in alpha IIb beta 3 (GPIIb-IIIa) receptor function. J Biol Chem. 1994 Aug 19;269(33):20913–20919. [PubMed] [Google Scholar]
  4. Baker E. K., Tozer E. C., Pfaff M., Shattil S. J., Loftus J. C., Ginsberg M. H. A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1973–1978. doi: 10.1073/pnas.94.5.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bennett J. S., Shattil S. J., Power J. W., Gartner T. K. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex. J Biol Chem. 1988 Sep 15;263(26):12948–12953. [PubMed] [Google Scholar]
  6. Calvete J. J., Alvarez M. V., Rivas G., Hew C. L., Henschen A., González-Rodríguez J. Interchain and intrachain disulphide bonds in human platelet glycoprotein IIb. Localization of the epitopes for several monoclonal antibodies. Biochem J. 1989 Jul 15;261(2):551–560. doi: 10.1042/bj2610551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Charo I. F., Nannizzi L., Phillips D. R., Hsu M. A., Scarborough R. M. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. J Biol Chem. 1991 Jan 25;266(3):1415–1421. [PubMed] [Google Scholar]
  8. Chen Y. P., Djaffar I., Pidard D., Steiner B., Cieutat A. M., Caen J. P., Rosa J. P. Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10169–10173. doi: 10.1073/pnas.89.21.10169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coller B. S. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest. 1997 Apr 1;99(7):1467–1471. doi: 10.1172/JCI119307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. D'Souza S. E., Ginsberg M. H., Burke T. A., Lam S. C., Plow E. F. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science. 1988 Oct 7;242(4875):91–93. doi: 10.1126/science.3262922. [DOI] [PubMed] [Google Scholar]
  11. D'Souza S. E., Ginsberg M. H., Burke T. A., Plow E. F. The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its alpha subunit. J Biol Chem. 1990 Feb 25;265(6):3440–3446. [PubMed] [Google Scholar]
  12. D'Souza S. E., Ginsberg M. H., Matsueda G. R., Plow E. F. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature. 1991 Mar 7;350(6313):66–68. doi: 10.1038/350066a0. [DOI] [PubMed] [Google Scholar]
  13. D'Souza S. E., Haas T. A., Piotrowicz R. S., Byers-Ward V., McGrath D. E., Soule H. R., Cierniewski C., Plow E. F., Smith J. W. Ligand and cation binding are dual functions of a discrete segment of the integrin beta 3 subunit: cation displacement is involved in ligand binding. Cell. 1994 Nov 18;79(4):659–667. doi: 10.1016/0092-8674(94)90551-7. [DOI] [PubMed] [Google Scholar]
  14. Frelinger A. L., 3rd, Lam S. C., Plow E. F., Smith M. A., Loftus J. C., Ginsberg M. H. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem. 1988 Sep 5;263(25):12397–12402. [PubMed] [Google Scholar]
  15. Ginsberg M. H., Lightsey A., Kunicki T. J., Kaufmann A., Marguerie G., Plow E. F. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. J Clin Invest. 1986 Oct;78(4):1103–1111. doi: 10.1172/JCI112667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grimaldi C. M., Chen F., Wu C., Weiss H. J., Coller B. S., French D. L. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa. Blood. 1998 Mar 1;91(5):1562–1571. [PubMed] [Google Scholar]
  17. Gulino D., Boudignon C., Zhang L. Y., Concord E., Rabiet M. J., Marguerie G. Ca(2+)-binding properties of the platelet glycoprotein IIb ligand-interacting domain. J Biol Chem. 1992 Jan 15;267(2):1001–1007. [PubMed] [Google Scholar]
  18. Heidenreich R., Eisman R., Surrey S., Delgrosso K., Bennett J. S., Schwartz E., Poncz M. Organization of the gene for platelet glycoprotein IIb. Biochemistry. 1990 Feb 6;29(5):1232–1244. doi: 10.1021/bi00457a020. [DOI] [PubMed] [Google Scholar]
  19. Higuchi R., Krummel B., Saiki R. K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988 Aug 11;16(15):7351–7367. doi: 10.1093/nar/16.15.7351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Honda S., Tomiyama Y., Pelletier A. J., Annis D., Honda Y., Orchekowski R., Ruggeri Z., Kunicki T. J. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit. J Biol Chem. 1995 May 19;270(20):11947–11954. doi: 10.1074/jbc.270.20.11947. [DOI] [PubMed] [Google Scholar]
  21. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  22. Irie A., Kamata T., Takada Y. Multiple loop structures critical for ligand binding of the integrin alpha4 subunit in the upper face of the beta-propeller mode 1. Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7198–7203. doi: 10.1073/pnas.94.14.7198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kamata T., Irie A., Tokuhira M., Takada Y. Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). J Biol Chem. 1996 Aug 2;271(31):18610–18615. doi: 10.1074/jbc.271.31.18610. [DOI] [PubMed] [Google Scholar]
  24. Kamata T., Wright R., Takada Y. Critical threonine and aspartic acid residues within the I domains of beta 2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J Biol Chem. 1995 May 26;270(21):12531–12535. doi: 10.1074/jbc.270.21.12531. [DOI] [PubMed] [Google Scholar]
  25. Kashiwagi H., Tomiyama Y., Honda S., Kosugi S., Shiraga M., Nagao N., Sekiguchi S., Kanayama Y., Kurata Y., Matsuzawa Y. Molecular basis of CD36 deficiency. Evidence that a 478C-->T substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest. 1995 Mar;95(3):1040–1046. doi: 10.1172/JCI117749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kodandapani R., Veerapandian B., Kunicki T. J., Ely K. R. Crystal structure of the OPG2 Fab. An antireceptor antibody that mimics an RGD cell adhesion site. J Biol Chem. 1995 Feb 3;270(5):2268–2273. doi: 10.1074/jbc.270.5.2268. [DOI] [PubMed] [Google Scholar]
  27. Kouns W. C., Steiner B., Kunicki T. J., Moog S., Jutzi J., Jennings L. K., Cazenave J. P., Lanza F. Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood. 1994 Aug 15;84(4):1108–1115. [PubMed] [Google Scholar]
  28. Lanza F., Stierlé A., Fournier D., Morales M., André G., Nurden A. T., Cazenave J. P. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation. J Clin Invest. 1992 Jun;89(6):1995–2004. doi: 10.1172/JCI115808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lee J. O., Rieu P., Arnaout M. A., Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell. 1995 Feb 24;80(4):631–638. doi: 10.1016/0092-8674(95)90517-0. [DOI] [PubMed] [Google Scholar]
  30. Loftus J. C., Halloran C. E., Ginsberg M. H., Feigen L. P., Zablocki J. A., Smith J. W. The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3. J Biol Chem. 1996 Jan 26;271(4):2033–2039. doi: 10.1074/jbc.271.4.2033. [DOI] [PubMed] [Google Scholar]
  31. Loftus J. C., Liddington R. C. Cell adhesion in vascular biology. New insights into integrin-ligand interaction. J Clin Invest. 1997 May 15;99(10):2302–2306. doi: 10.1172/JCI119408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Loftus J. C., O'Toole T. E., Plow E. F., Glass A., Frelinger A. L., 3rd, Ginsberg M. H. A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science. 1990 Aug 24;249(4971):915–918. doi: 10.1126/science.2392682. [DOI] [PubMed] [Google Scholar]
  33. Loftus J. C., Plow E. F., Frelinger A. L., 3rd, D'Souza S. E., Dixon D., Lacy J., Sorge J., Ginsberg M. H. Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7114–7118. doi: 10.1073/pnas.84.20.7114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. McEver R. P., Bennett E. M., Martin M. N. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies. J Biol Chem. 1983 Apr 25;258(8):5269–5275. [PubMed] [Google Scholar]
  35. McKay B. S., Annis D. S., Honda S., Christie D., Kunicki T. J. Molecular requirements for assembly and function of a minimized human integrin alphaIIbbeta3. J Biol Chem. 1996 Nov 29;271(48):30544–30547. doi: 10.1074/jbc.271.48.30544. [DOI] [PubMed] [Google Scholar]
  36. Michishita M., Videm V., Arnaout M. A. A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell. 1993 Mar 26;72(6):857–867. doi: 10.1016/0092-8674(93)90575-b. [DOI] [PubMed] [Google Scholar]
  37. Newman P. J., Allen R. W., Kahn R. A., Kunicki T. J. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood. 1985 Jan;65(1):227–232. [PubMed] [Google Scholar]
  38. Phillips D. R., Charo I. F., Scarborough R. M. GPIIb-IIIa: the responsive integrin. Cell. 1991 May 3;65(3):359–362. doi: 10.1016/0092-8674(91)90451-4. [DOI] [PubMed] [Google Scholar]
  39. Pidard D., Montgomery R. R., Bennett J. S., Kunicki T. J. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem. 1983 Oct 25;258(20):12582–12586. [PubMed] [Google Scholar]
  40. Rosa J. P., Bray P. F., Gayet O., Johnston G. I., Cook R. G., Jackson K. W., Shuman M. A., McEver R. P. Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17. Blood. 1988 Aug;72(2):593–600. [PubMed] [Google Scholar]
  41. Ruoslahti E. Integrins. J Clin Invest. 1991 Jan;87(1):1–5. doi: 10.1172/JCI114957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shattil S. J., Hoxie J. A., Cunningham M., Brass L. F. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem. 1985 Sep 15;260(20):11107–11114. [PubMed] [Google Scholar]
  43. Shiraga M., Tomiyama Y., Honda S., Kashiwagi H., Kosugi S., Handa M., Ikeda Y., Kanakura Y., Kurata Y., Matsuzawa Y. Affinity modulation of the platelet integrin alpha IIb beta 3 by alpha-chymotrypsin: a possible role for Na+/Ca2+ exchanger. Blood. 1996 Oct 1;88(7):2594–2602. [PubMed] [Google Scholar]
  44. Springer T. A. Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):65–72. doi: 10.1073/pnas.94.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Taub R., Gould R. J., Garsky V. M., Ciccarone T. M., Hoxie J., Friedman P. A., Shattil S. J. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem. 1989 Jan 5;264(1):259–265. [PubMed] [Google Scholar]
  46. Tokuhira M., Handa M., Kamata T., Oda A., Katayama M., Tomiyama Y., Murata M., Kawai Y., Watanabe K., Ikeda Y. A novel regulatory epitope defined by a murine monoclonal antibody to the platelet GPIIb-IIIa complex (alpha IIb beta 3 integrin). Thromb Haemost. 1996 Dec;76(6):1038–1046. [PubMed] [Google Scholar]
  47. Tomiyama Y., Brojer E., Ruggeri Z. M., Shattil S. J., Smiltneck J., Gorski J., Kumar A., Kieber-Emmons T., Kunicki T. J. A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3. J Biol Chem. 1992 Sep 5;267(25):18085–18092. [PubMed] [Google Scholar]
  48. Tomiyama Y., Kashiwagi H., Kosugi S., Shiraga M., Kanayama Y., Kurata Y., Matsuzawa Y. Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann's thrombasthenia. Thromb Haemost. 1995 May;73(5):756–762. [PubMed] [Google Scholar]
  49. Tomiyama Y., Kashiwagi H., Kosugi S., Shiraga M., Kinoshita S., Kanayama Y., Kurata Y., Matsuzawa Y. Demonstration of a marked reduction in the amount of GPIIb in most type II patients with Glanzmann's thrombasthenia. Br J Haematol. 1994 May;87(1):119–124. doi: 10.1111/j.1365-2141.1994.tb04880.x. [DOI] [PubMed] [Google Scholar]
  50. Tomiyama Y., Tsubakio T., Piotrowicz R. S., Kurata Y., Loftus J. C., Kunicki T. J. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood. 1992 May 1;79(9):2303–2312. [PubMed] [Google Scholar]
  51. Zucker M. B., Masiello N. C. Platelet aggregation caused by dithiothreitol. Thromb Haemost. 1984 Feb 28;51(1):119–124. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES